Law360, New York (December 02, 2011, 2:57 PM ET) -- The U.S. Supreme Court is set to hear oral arguments on Wednesday in a closely watched case over the patentability of a blood test method that attorneys say could elaborate on last year's Bilski decision in establishing what makes an invention eligible for a patent.
The high court granted certiorari in June to Mayo Collaborative Services, which argues that a patent on a testing method held by Prometheus Laboratories Inc., and ruled valid by the Federal Circuit, provides an unlawful monopoly on a natural phenomenon and...
Mayo Case Could Clarify Patentability, Expand On Bilski
To view the full article, take a free trial now.
